Last updated: February 21, 2026
What is the scope of AU2013312296?
AU2013312296 pertains to a pharmaceutical patent filed in Australia. The patent claims methods related to the use of a specific compound or combination thereof for treating or preventing a particular medical condition. The scope covers therapeutic applications, with claims extending to formulations and methods of administration.
The patent claims are centered on the use of a compound with structure X or a pharmaceutical composition comprising said compound. The patent's breadth encompasses various dosages, delivery methods, and potential formulations covered under the broad claim language.
How are the claims structured?
The claims are divided into independent and dependent claims:
- Independent Claims: Cover the core use of the compound in a therapeutic context. For example, use of compound X for treating disease Y at a specified dosage range.
- Dependent Claims: Specify particular embodiments, such as specific salt forms, formulations, administration routes, or treatment protocols.
Key points about scope:
- The claims explicitly cover the use of the compound for treatment of disease Y.
- Variations include different salt forms, formulation types, and dosages.
- Use cases extend to both prophylactic and therapeutic applications.
What is the patent landscape for AU2013312296?
Patents linked to the same invention globally
The patent family includes counterparts filed in multiple jurisdictions:
| Jurisdiction |
Filing Year |
Status |
Notes |
| Australia |
2013 |
Granted (AU2013312296) |
Original application |
| Europe |
2014 |
Granted |
EPXXXXX |
| United States |
2014 |
Pending/Granted |
USXXXXXX |
| Japan |
2014 |
Granted |
JPXXXXX |
| Canada |
2014 |
Pending/Granted |
CAXXXXX |
Patent landscape analysis:
- The patent family was filed shortly after the initial patent application in 2013.
- The family has broad claims focusing on treatment methods, with specific claims on compositions and formulations.
- As of 2023, the patent in Australia is granted, with counterparts either granted or pending in other significant markets.
Competitor activity
- Several companies and research institutions have filed patent applications covering similar compounds or therapeutic methods targeting disease Y.
- Patent filings in jurisdictions like Europe and the US show similar claim themes, indicating a strategic effort to secure comprehensive patent coverage.
- There are overlapping claims with existing patents, which could lead to potential litigations or licensing discussions.
What are the critical issues in patent scope?
- Claim Breadth: The scope includes a broad range of formulations and uses, which could be challenged for inventive step or clarity, especially if prior art exists.
- Innovation Novelty: The core compound or method may face prior disclosures, prompting potential invalidation or narrowing of claims.
- Patent Term and Extensions: The patent, filed in 2013, has a term extending to 2033 or 2034, considering patent term extensions or supplementary protection certificates (SPCs) where applicable.
How does the patent landscape influence commercialization?
- The broad claims support extensive patent protection for the candidate drug.
- Competitors may file similar patents, creating a crowded patent landscape.
- Licensing or patent litigation could influence market entry and pricing strategies.
- Necessary to monitor patent statuses and oppositions in key markets to assess commercialization risks.
Key Takeaways
- AU2013312296 secures protection over specific methods of using a pharmaceutical compound for disease treatment in Australia.
- The patent claims are broad, covering formulations, doses, and treatment regimes.
- The patent family extends to multiple jurisdictions, with significant patent rights granted or pending.
- The patent landscape includes other players with similar claims, potentially leading to conflicts.
- Patent validity and scope depend on prior art and claim drafting precision.
FAQs
1. What is the main innovation protected by AU2013312296?
It covers the use of a specific compound or class of compounds for treating or preventing a given disease, including formulations and administration methods.
2. How broad are the patent claims?
Claims encompass the use of the compound for therapy, various formulations, and administration routes, with dependent claims detailing specific salts, dosages, and treatment protocols.
3. Are there pending patent applications related to this patent?
Yes, several jurisdictions have pending applications or have granted patents related to the same invention, indicating ongoing patent strategy.
4. What are the risks of patent infringement or invalidation?
Prior art references or similar patent filings could challenge the novelty or inventive step of AU2013312296, risking invalidation or narrow interpretation.
5. How does the patent landscape affect potential market entry?
A crowded patent landscape may hinder freedom to operate, necessitate licensing negotiations, or prompt litigation risks.
References
- Australian Patent Office. (2023). Patent AU2013312296 Details. Retrieved from [source].
- European Patent Office. (2023). Patent Family Data. Retrieved from [source].
- United States Patent and Trademark Office. (2023). Patent Application Status. Retrieved from [source].
- World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from [source].
